Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) through any online brokerage.
Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Ionis Pharmaceuticals (NASDAQ:IONS).
Crinetics Pharmaceuticals has a consensus price target of $65.85.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $55.96 last updated October 31, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.